Holding website  

  • About Us
    • What we do
      • Strategic Approach
    • Management Team
    • Collaboration & Partnering
    • Investors
    • Careers
      • Open Positions
        • Head of Medical Affairs
    • Privacy
  • APR Products
    • Prescription Healthcare Products
      • PKU GOLIKE® Family
      • Nexodyn® – Advanced Wound Care
        • Tehclo Technology
      • Diclofenac Immediate Release
        • Immediate Release Technology
        • Diclofenac 50 mg products
      • Ondansetron ODF
        • ODF Technology
        • Ondansetron ODF products
      • APR TD011 – Epidermolysis Bullosa
        • Tehclo Technology
      • APR TD012 – Hailey Hailey Disease
        • Tehclo Technology
      • APR 1204 – Ocular Surface Diseases
        • Tehclo Technology
      • Exelya®
        • Exelya®
        • Tehclo Technology
    • Consumer Healthcare Products
      • Acute Pain
        • Diclofenac 25 mg products
      • Healthy Aging – SwitzAge™
      • Pediatric
        • Halykoo
    • Therapeutical Areas
      • Inherited Metabolic Disorders
        • What is PKU (Phenylketonuria)?
      • Advanced Wound Care
        • Unmet Medical Need
      • Cancer Supportive Care
        • Nausea and vomiting
        • Oncodermatology
      • CNS (migraine)
      • Rare Dermatological Diseases
        • Epidermolysis Bullosa
        • Hailey Hailey Disease
      • Eye laser surgery
    • Pipeline
  • Our Services
    • Solid Dosage Forms
      • Oral Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Oral Nutraceuticals
        • Integrated project development
        • Project design planning
      • Oral Medical Devices
        • Integrated project development
        • Project design planning
    • Non-Solid Dosage Forms
      • Topical Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Topical Dermocosmetics
        • Integrated project development
        • Project design planning
      • Topical Medical Devices
        • Integrated project development
        • Project design planning
    • Analytical Services
    • Certifications
  • Media
    • Presentations
    • Press Releases
  • Contacts
    • Location
    • Vigilance
    • APR LAB

Discover who we are and our partners global network, as well as learn more about our people.

Learn more about our products and how they provide innovative solutions for patiens' unmet needs.

Discover our capabilities in project design services.

Find information such as website news, press releases and event presentations.

Get in touch with us to set up a meeting or propose your cooperation.

 

Holding website  

  • About Us
    • What we do
      • Strategic Approach
    • Management Team
    • Collaboration & Partnering
    • Investors
    • Careers
      • Open Positions
        • Head of Medical Affairs
    • Privacy
  • APR Products
    • Prescription Healthcare Products
      • PKU GOLIKE® Family
      • Nexodyn® – Advanced Wound Care
        • Tehclo Technology
      • Diclofenac Immediate Release
        • Immediate Release Technology
        • Diclofenac 50 mg products
      • Ondansetron ODF
        • ODF Technology
        • Ondansetron ODF products
      • APR TD011 – Epidermolysis Bullosa
        • Tehclo Technology
      • APR TD012 – Hailey Hailey Disease
        • Tehclo Technology
      • APR 1204 – Ocular Surface Diseases
        • Tehclo Technology
      • Exelya®
        • Exelya®
        • Tehclo Technology
    • Consumer Healthcare Products
      • Acute Pain
        • Diclofenac 25 mg products
      • Healthy Aging – SwitzAge™
      • Pediatric
        • Halykoo
    • Therapeutical Areas
      • Inherited Metabolic Disorders
        • What is PKU (Phenylketonuria)?
      • Advanced Wound Care
        • Unmet Medical Need
      • Cancer Supportive Care
        • Nausea and vomiting
        • Oncodermatology
      • CNS (migraine)
      • Rare Dermatological Diseases
        • Epidermolysis Bullosa
        • Hailey Hailey Disease
      • Eye laser surgery
    • Pipeline
  • Our Services
    • Solid Dosage Forms
      • Oral Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Oral Nutraceuticals
        • Integrated project development
        • Project design planning
      • Oral Medical Devices
        • Integrated project development
        • Project design planning
    • Non-Solid Dosage Forms
      • Topical Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Topical Dermocosmetics
        • Integrated project development
        • Project design planning
      • Topical Medical Devices
        • Integrated project development
        • Project design planning
    • Analytical Services
    • Certifications
  • Media
    • Presentations
    • Press Releases
  • Contacts
    • Location
    • Vigilance
    • APR LAB
VIGILANCE
KENNTNISNAHME DER DATENSCHUTZINFORMATION UND EINWILLIGUNGSERKLÄRUNG
* E-Mail-Adresse:
  Betreff:
  Telefonnummer:
* Produkt:
* Beschreibung des Problems:
* Pflichtfelder.
* Bitte geben Sie bei der Beschreibung des Problems Symptome, Anzeichen, Krankheit und/oder Unfall an.


Erklärung zur Datenschutzrichtlinie und Einwilligung
Mit diesem Dokument informiert Sie APR Applied Pharma Research s.a. ("APR") darüber, dass die Informationen, die Sie über diese Webseite übermitteln, mit Ihrer Einwilligung und im Rahmen des Bundesdatenschutzgesetzes vom 19. Juni 1992 und der DSGVO verarbeitet und verwendet werden.

APR verarbeitet Ihre Daten, und zwar insbesondere:

  • Ihren Vor- und Nachnamen
  • E-Mail-Adresse und Telefonnummer
  • Geburtsdatum
  • Symptome, ungünstige und außergewöhnliche Anzeichen (z.B. abweichende Laborergebnisse) und Krankheiten, die durch die Verwendung eines bestimmten Produkts verursacht werden

zu dem einzigen Zweck, um Ihre Fragen, soweit erforderlich und so, wie von Ihnen angefordert, zu beantworten, und um gesetzliche oder andere behördliche Anforderungen zu erfüllen.

APR ist ein Schweizer Unternehmen mit Sitz in Balerna. Deshalb werden Ihre Daten außerhalb der Europäischen Union übertragen und verarbeitet.

Sie können jederzeit ihre von der DSGVO gewährten Rechte ausüben, insbesondere die Löschung, Änderung, Aktualisierung der Daten und den Widerspruch gegen ihre weitere Verarbeitung, indem Sie sich schriftlich an APR oder die folgende E-Mail-Adresse wenden: privacy@apr.ch.

* Ich erkläre, dass ich die Erklärung zur Datenschutzrichtlinie gelesen habe und in die Verarbeitung meiner personenbezogenen Daten einwillige.

Privacy policy

This policy is based on the principles set out in Swiss federal law governing data protection, enacted on June 19, 1992 and in the GDPR and is aimed to protect the character and fundamental rights of individuals whose data are processed by APR.

APR informs you that your personal information (and in general any data you will provide through this Site) shall be processed by APR with the exclusive purpose to answer to your request and only with your express consent. Nonetheless, APR recall your attention on the fact that the computer systems and software procedures in operation for running this Site automatically acquire some personal data, solely for the use of Internet communication protocols. While such information is not gathered to be matched to specific individuals, it could, by its very nature, enable identification of users, through development and linkage to data held by third parties. APR warrants that is shall not use the data and information collected through this Site to identify you.

The voluntary transmission of electronic mail to the addresses shown on this Site involves the automatic acquisition of the sender’s address, in order to reply to the requests, as well as of any other personal data entered.

Once your data are shown in the form on the previous page “Declaration acknowledging review of privacy policy and consent” - where problems are reported, you expressly declare that you are aware of, understand, and accept the terms and conditions for protection of personal data as they are set out.

DEFINITIONS

  • “APR” refers to APR Applied Pharma Research s.a. with registered headquarters at 5 Via Corti, Balerna, 6828, Switzerland.
  • “Cookie” refers to a small data file created by our site and archived on your computer’s hard disk.
  • “Data protection legislation” refers to Swiss federal law on data protection, enacted on June 19, 1992 and GDPR.
  • “Personal data” refers to the data of any identified or identifiable individual who uses this site as described in the data protection legislation.
  • “Interested persons” refers to individuals or legal entities whose data are being processed.
  • “Processing” refers to any data related operation, notwithstanding the means and procedures used (for example, the gathering, storage, use, modification, communication, archiving, and/or destruction of data).
  • “Rules” refers to the privacy rules on this site.
  • “Site” refers to APR’s website.
  • “Third party provider” refers to third parties that provide APR with services upon signature of an agreement.
  • “Clients” refers to patients or health workers who use APR’s products.

SCOPE

The following Rules govern how APR gathers, processes, and archives your personal data on this Site. When you report a problem by filling the form on the previous page, you agree to be bound by these Rules. Your personal data must be provided to ensure your report is processed. Filling in your personal data is optional, but your refusal to provide these details means we cannot follow up on your report. You have the right not to insert your personal data if you do not accept these Rules, but we will be unable to follow up on your report. Since APR reserves the right to change these Rules anytime, we ask you to review them regularly. This privacy policy does not apply to external sites to which this website may direct its visitors. We therefore suggest that you be informed of the content of every site you visit.


DATA GATHERING AND PROCESSING

Your personal data will be processed by APR for the sole purpose of following up on your report. By sending APR your personal data, you agree that APR can process said data for the purposes for which you have provided the data.

The personal data provided will be processed by APR, for the sole purpose of following up on reports/requests received by electronic means, in compliance with the objectives and security measures set out in data protection legislation. Interested parties may contact APR anytime, by sending an email to privacy@apr.ch to exercise their rights and, especially, access data about themselves, and request corrections, updates, or the cancellation of such data.


SHARING YOUR PERSONAL DATA

APR may share your personal data with the other companies of its group, as well as affiliates and entities under its control and, within a global vigilance system and with the aim to safeguard the health and wellbeing of the patients and users of its product, it might also share data, in anonymous form, with third parties that might be located inside or outside Switzerland. Your compliance with these Rules means you accept that the country in which your personal data (in anonymous form) are received may offer a different, incomparable, or inadequate level of data protection compared to that offered by data protection legislation or the Convention for the Protection of Individuals with regard to Automatic Processing of Personal Data that was signed in Strasbourg on January 28, 1981; legislation that may be amended over time.


OBLIGATION TO INFORM WHEN GATHERING SENSITIVE PERSONAL DATA

If sensitive personal data (data worthy of special protection – for example, pertaining to health, intimate matters, or race) are collected and processed APR shall inform the interested party, as well as in the event such data are collected and processed by third parties. This obligation does not apply when the person has already been informed about such collection and processing of its data.


ACCESS TO YOUR PERSONAL DATA

Pursuant to data protection legislation, you may ask to check if any, and what, personal data about you is in APR’s possession by writing to privacy@apr.ch. APR shall provide you with the requested information.


DATA RETENTION

Even if APR commits to retain your personal data for no longer than the time needed to fulfill the purpose for which you provided said data, APR could be required by law to keep your personal data on file for longer than the duration of the transaction that led to the data gathering process, saved your right to require their cancellation in any time.


SECURITY AND CONFIDENTIALITY

APR will take all technical and organizational measures to guarantee that your personal data will be protected from accidental or illegal destruction, accidental loss, alteration, unauthorized viewing or access, and to offer a level of security commensurate with the risk inherent in processing the personal data and with the nature of said data. Technological advances enable APR to prepare future security measures and to continue safeguarding you and your privacy.

In sending your personal data to APR, you agree that such data may be shared within APR and the APR Group (within the limits of the applicable laws and for the purposes herein specified). APR will guarantee that the companies in the APR Group will take the necessary measures to keep your personal data confidential and secure. Your personal data may only be gathered, processed, and accessed by authorized personnel at APR, the companies in the APR Group.

Back

APR 2015 all rights reserved | About us | APR Products | Our services | News & Events | Contact | Privacy policy | Cookie policy | Sitemap